# Treatment of Laryngotracheal Stenosis Using Mesenchymal Stem Cells

> **NCT03130374** · PHASE1,PHASE2 · COMPLETED · sponsor: **The Republican Research and Practical Center for Epidemiology and Microbiology** · enrollment: 12 (estimated)

## Conditions studied

- Tracheal Stenosis
- Laryngeal Stenosis
- Mesenchymal Stem Cells

## Interventions

- **BIOLOGICAL:** Olfactory mucosa-derived mesenchymal stem cells

## Key facts

- **NCT ID:** NCT03130374
- **Lead sponsor:** The Republican Research and Practical Center for Epidemiology and Microbiology
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-03
- **Primary completion:** 2019-01-04
- **Final completion:** 2019-05-20
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2019-06-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03130374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03130374, "Treatment of Laryngotracheal Stenosis Using Mesenchymal Stem Cells". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03130374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*